drugset / Trial / NCT02183389
Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male Volunteers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To investigate whether and to what extent BI 1356 affects pharmacokinetic and pharmacodynamic parameters of warfarin
Timeline
- Start
- 2008-05
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Small molecule | 5 mg | Oral |
| Subject | Warfarin | Small molecule | 10 mg | Oral |
Indications
No indication recorded.